Are GOLD ABCD groups better associated with health status and costs than GOLD 1234 grades? A cross-sectional study

Primary Care Respiratory Journal

Volumn 23, Issue 1, 2014, Pages 30-37

  Boland, Melinde R S ^a   Tsiachristas, Apostolos ^a   Kruis, Annemarije L ^b   Chavannes, Niels H ^b   Rutten van Mölken, Maureen P M H ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chronic obstructive pulmonary disease; Economics; Primary care

Indexed keywords

AGE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT TOOL; COMORBIDITY; CROSS-SECTIONAL STUDY; DRUG COST; EDUCATIONAL STATUS; ELECTRONIC MEDICAL RECORD; EMPLOYMENT; FEMALE; FUNCTIONAL STATUS; GENDER; GENERAL PRACTICE; GOLD 1234 GRADES CLASSIFICATION; GOLD ABCD GROUPS CLASSIFICATION; HEALTH CARE COST; HEALTH STATUS; HUMAN; INTERMETHOD COMPARISON; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PHYSICAL ACTIVITY; PREVALENCE; PRIMARY MEDICAL CARE; QUALITY OF LIFE; SCORING SYSTEM; SMOKING; SOCIAL STATUS; AGED; CLASSIFICATION; COST; ECONOMICS; PATHOPHYSIOLOGY;

AGED; COSTS AND COST ANALYSIS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE;

EID: 84895146654     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2014.00002     Document Type: Article

References (31)

1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Revised 2011. http://www.goldcopd.org/uploads/users/files/GOLD2011_Summary.pdf
2. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54(7):581-6. http://dx.doi.org/10.1136/thx.54.7.581
3. Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD assessment test. Eur Respir J 2009;34(3):648-54. http://dx.doi.org/10.1183/09031936.00102509
4. Lange P, Marott JL, Vestbo J, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med 2012;186(10):975-81. http://dx.doi.org/ 10.1164/rccm.201207-1299OC
5. Han M, Muellerova H, Curran-Everett D, et al. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med 2013;1:43-50. http://dx.doi.org/10.1016/S2213-2600(12)70044-9
6. Soriano JB, Alfageme I, Almagro P, et al. Distribution and prognostic validity of the new GOLD grading classification. Chest 2013;143:694-702.
7. Agusti A, Edwards LD, Celli B, et al. Characteristics, stability and outcomes of the GOLD 2011 COPD groups in the ECLIPSE cohort. Eur Respir J 2013;42:636-46. http://dx.doi.org/10.1183/09031936.00195212
8. Johannessen A, Nilsen RM, Storebo M, Gulsvik A, Eagan T, Bakke P. Comparison of 2011 and 2007 global initiative for chronic obstructive lung disease guidelines for predicting mortality and hospitalization. Am J Respir Crit Care Med 2013;188(1):51-9. http://dx.doi.org/10.1164/rccm.201212-2276OC
9. Leivseth L, Brumpton BM, Nilsen TI, Mai XM, Johnsen R, Langhammer A. GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT study, Norway. Thorax 2013;68(10):914-21. http://dx.doi.org/10.1136/thoraxjnl-2013-203270
10. van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003;1:13. http://dx.doi.org/10.1186/1477-7525-1-13
11. Kocks JW, Tuinenga MG, Uil SM, van den Berg JW, Stahl E, van der Molen T. Health status measurement in COPD: The minimal clinically important difference of the clinical COPD questionnaire. Respir Res 2006;7:62. http://dx.doi.org/10.1186/1465-9921-7-62
12. Jones PW. St. George's Respiratory Questionnaire: MCID. COPD 2005;2(1):75-9. http://dx.doi.org/10.1081/COPD-200050513
13. Aaronson NK, Muller M, Cohen PD, et al. Translation, validation, and norming of the Dutch language version of the SF-36 health survey in community and chronic disease populations. J Clin Epidemiol 1998;51(11):1055-68. http://dx.doi.org/10.1016/S0895-4356(98)00097-3
14. Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30(6):473-83. http://dx.doi.org/10.1097/00005650-199206000-00002
15. Brazier J, Roberts J, Tsuchiya A, Busschbach J. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 2004;13(9):873-84. http://dx.doi.org/10.1002/hec.866
16. Robinson A, Dolan P, Williams A. Valuing health status using VAS and TTO: What lies behind the numbers? Soc Sci Med 1997;45(8):1289-97. http://dx.doi.org/10.1016/S0277-9536(97)00057-9
17. Lamers LM, McDonnell J, Stalmeier PF, Krabbe PF, Busschbach JJ. The Dutch tariff: Results and arguments for an effective design for national EQ-5D valuation studies. Health Econ 2006;15(10):1121-32. http://dx.doi.org/10.1002/hec.1124
18. Charlson ME, Charlson RE, Peterson JC, Marinopoulos SS, Briggs WM, Hollenberg JP. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol 2008;61(12):1234-40. http://dx.doi.org/10.1016/j.jclinepi.2008.01.006
19. Hakkaart-van Roijen L, Tan S, Bouwmans C. Handleiding voor kostenonderzoek, methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg. 2010.
20. Consumentenprijzen: inflatie vanaf 1963. http://statline.cbs.nl/StatWeb/
21. GIPdatabank. http://www.gipdatabank.nl/
22. Koopmanschap MA, Rutten FF, van Ineveld BM, van Roijen L. The friction cost method for measuring indirect costs of disease. J Health Econ 1995;14(2):171-89. http://dx.doi.org/10.1016/0167-6296(94)00044-5
23. Verbeke G, Molenberghs G. Linear mixed models for longitudinal data. New York: Springer, 2005.
24. Snijders TAB, Bosker RJ. Modeled variance in two-level models. Sociol Methods Res 1994;22(3):342-63. http://dx.doi.org/10.1177/0049124194022003004
25. Hoogendoorn M, Feenstra TL, Schermer TR, Hesselink AE, Rutten-van Molken MP. Severity distribution of chronic obstructive pulmonary disease (COPD) in Dutch general practice. Respir Med 2006;100(1):83-6. http://dx.doi.org/10.1016/j.rmed.2005.04.004
26. Steuten LM, Creutzberg EC, Vrijhoef HJ, Wouters EF. COPD as a multicomponent disease: Inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care. Prim Care Respir J 2006;15(2):84-91. http://dx.doi.org/10.1016/j.pcrj.2005.09.001
27. Chavannes NH, Grijsen M, van den Akker M, et al. Integrated disease management improves one-year quality of life in primary care COPD patients: a controlled clinical trial. Prim Care Respir J 2009;18(3):171-6. http://dx.doi.org/10.3132/pcrj.2009.00003
28. Hoogendoorn M, van Wetering CR, Schols AM, Rutten-van Molken MP. Self-report versus care provider registration of healthcare utilization: impact on cost and costutility. Int J Technol Assess Health Care 2009;25(4):588-95. http://dx.doi.org/10.1017/S0266462309990432
29. Wedzicha JA. GOLD and ABCD-a good start, but now for the evidence? Lancet Respir Med 2013;1(1):4-5. http://dx.doi.org/10.1016/S2213-2600(12)70045-0
30. Vestbo J, Hurd SS, Rodriguez-Roisin R. The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD): why and what? Clin Respir J 2012;6(4):208-14. http://dx.doi.org/10.1111/crj.12002
31. LAN. Zorgstandaard COPD. Amersfoort: Long Alliantie Nederland; 2010.